Terushige Muraoka

Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets

Atsushi Ohta, Mikimasa Tanada, Shojiro Shinohara et al. · Journal of the American Chemical Society · 2023 · 86 citations

Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment

Futa Mimoto, K. Tatsumi, Shun Shimizu et al. · Cell Reports · 2020 · 62 citations · Full text

Cancer Immunosurveillance, Elevated Extracellular Atp, Medicine +15

Broadly Applicable and Comprehensive Synthetic Method for<i>N</i>-Alkyl-Rich Drug-like Cyclic Peptides

Kenichi Nomura, Satoshi Hashimoto, Ryuuichi Takeyama et al. · Journal of Medicinal Chemistry · 2022 · 32 citations

Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)

Terushige Muraoka, Mitsuaki Ide, Kenji Morikami et al. · Bioorganic & Medicinal Chemistry · 2016 · 14 citations · Full text

Molecular Pharmacology, Receptor-associated Kinase 1, Signal Transduction +14

Conformationally restricted analog and biotin-labeled probe based on beauveriolide III

Takayuki Doi, Terushige Muraoka, Taichi Ohshiro et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 12 citations · Full text

Biochemistry, Bioconjugation, Chemical Probe +4